US 8227188
Enhancement of influenza gene expression
granted A61PA61P31/16A61P43/00
Quick answer
US patent 8227188 (Enhancement of influenza gene expression) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P31/16, A61P43/00